Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimetazidine in Acute Aluminum Phosphide Poisoning
NCT04702906Unknown
- Sponsor
- Tanta University
- Start
- Feb 2021
- Primary completion
- Jun 2021
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of trimetazidine in aluminum phosphide poisoning (2 arms), sponsored by Tanta University. Primary endpoint: Mortality at 7 days. Status: unknown.
02
Drugs
trimetazidine
03
Conditions
aluminum phosphide poisoning
Beyond the preview
Go deeper on NCT04702906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04702906.